Bioactive surface modifiers for polymers and articles made therefrom
First Claim
1. A bioactive fluoroalkyl surface modifier for use in admixture with a compatible base polymer, said modifier having the general formula is a central portion comprising an oligomeric polymeric segment having a theoretical molecular weight of less than 15,000, and being compatible with said base polymer;
- wherein[oligo] is a first oligomeric segment;
[link A] is a second coupling segment linking one [oligo] to another [oligo] within said central portion;
n is 0 to 20;
[fluoro] is a polyfluoro oligomeric group; and
[link B] is a first coupling segment linking said central portion to said [fluoro] through said first coupling segment; and
coupled to a bioactive moiety [Bio] or precursor thereof; and
m is 1 to 20.
3 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to macromolecule modifiers containing biologically active drugs/biomolecules, or precursors thereof, and fluoroligomers; compositions comprising the macromolecules containing the drugs and fluoroligomers in admixture with polymers, particularly biomedical polymers; articles made from the admixtures, particularly medical devices. Specifically, the modifier has the general formula
is a central portion comprising an oligomeric polymeric segment having a theoretical molecular weight of less than 15,000, and being compatible with said base polymer; wherein
[oligo] is a first oligomeric segment;
[link A] is a second coupling segment linking one [oligo] to another [oligo] within said central portion;
n is 0 to 20;
[fluoro] is a polyfluoro oligomeric group; and
[link B] is a first coupling segment linking said central portion to said [fluoro] through said first coupling segment; and coupled to a bioactive moiety [Bio] or precursor thereof; and
m is 1 to 20.
43 Citations
22 Claims
-
1. A bioactive fluoroalkyl surface modifier for use in admixture with a compatible base polymer, said modifier having the general formula
is a central portion comprising an oligomeric polymeric segment having a theoretical molecular weight of less than 15,000, and being compatible with said base polymer; - wherein
[oligo] is a first oligomeric segment;
[link A] is a second coupling segment linking one [oligo] to another [oligo] within said central portion;
n is 0 to 20;
[fluoro] is a polyfluoro oligomeric group; and
[link B] is a first coupling segment linking said central portion to said [fluoro] through said first coupling segment; and
coupled to a bioactive moiety [Bio] or precursor thereof; and
m is 1 to 20. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
wherein n is 0-20; - and
m is 1-20;
provided that when n is 0, m is 1.
- wherein
-
3. A modifier as defined in claim 1 wherein said oligomeric polymeric segment has an absolute molecular weight of less than 10,000.
-
4. A modifier as defined in claim 3 wherein said oligomeric polymeric segment has an absolute molecular weight of less than 5,000.
-
5. A modifier as defined in claim 1 wherein said [oligo] is selected from the group consisting of polyurethane, polyurea, polyamides, polyalkylene oxide, polycarbonate, polyester, polylactone, polysilicone, polyethersulfone, polyolefin, polyvinyl derivative, polypeptide and polysaccharide segments.
-
6. A modifier as defined in claim 1 wherein said [link A] and [link B] are selected from the group consisting of an oligoamide;
- oligourethane;
oligourea;
oligosulphonate;
oligosulphonamide;
oligoester;
oligoacetal oligoimine segment, and combinations thereof.
- oligourethane;
-
7. A modifier as defined in claim 1 wherein said [fluoro] has a molecular weight selected from 100 to 1500.
-
8. A modifier as defined in claim 1 wherein said [fluoro] is selected from the group consisting of radicals of the general formula CF3(CF2)pCH2CH2—
- wherein p is 2-20 and CF3(CF2)m(CH2CH2O)q- wherein q is 1-10 and m is 1-20.
-
9. A modifier as defined in claim 8 wherein said [fluoro] is C8F17CH2CH2-.
-
10. A modifier as defined in claim 1 wherein said bioactive moiety [Bio] is selected from the group consisting of an anti-inflammatory, anti-coagulant, anti-oxidant, antibiotic, cell receptor ligand, bioadhesive molecular, oligonucleic acid and phospholipid compound.
-
11. A modifier as defined in claim 10 wherein said bioactive material is selected from the group consisting of fluoroquinolone, Heparin, Hyaluronic acid, Vitamin E, peptide, hydrocortisone and L-α
- glycerophosphoryl choline.
-
12. A modifier as defined in claim 11 wherein said peptide is selected from GGRGD (SEQ ID NO:
- 5), YRGDG (SEQ ID NO;
3) and RGDSPASSKP (SEQ ID NO;
4).
- 5), YRGDG (SEQ ID NO;
-
13. A modifier as defined in claim 1 wherein n is 2 to 10.
-
14. A composition comprising a bioactive fluoroalkyl surface modifier as defined in claim 1 in admixture with said compatible base polymer.
-
15. A composition as defined in claim 14 wherein said base polymer is selected from the group consisting of polyurethanes, polysulfones, polycarbonates, polysaccharide, polyesters, polyethylene, polypropylene, polystyrene, poly(acrylonitrile-butadienestyrene), polybutadiene, polyisoprene, styrenebutadiene-styrene block copolymers, styrene-iso-prenestyrene block copolymers, poly-r-methylpentene, polyisobutylene, polymethyl-methacrylate, polyvinylacetate-polyacrylonitrile, polyvinyl chloride, polyethylene terephthalate, cellulose and its esters and derivatives, polyamides, polyester-polyethers, styrene-isoprenes, styrene butadienes, thermoplastic polyolefins, styrene-saturated olefins, polyester-polyester, ethylene-vinyl acetate ethylene-ethyl acrylate, ionomers, and thermoplastic polydienes.
-
16. A composition as defined in claim 15 wherein said base polymer is segmented polyurethane.
-
17. A composition as defined in claim 15 wherein said base polymer is selected from the group consisting of a polysilicone, a polyester, and a polysaccharide.
-
18. A composition as defined in claim 14 comprising 0.5 to 10 w/w % of said modifier.
-
19. A composition as defined in claim 18 comprising 1 to 5 w/w % of said modifier.
-
20. A composition as defined in claim 14 in the form of a shaped article.
-
21. A shaped article as defined in claim 20 in the form of an implantable medical device, self-supporting film, or fiber.
-
22. A modifier having the general formula
wherein [[oligo]-(link A-[oligo])n] is a central portion comprising an oligomeric polymeric segment having a theoretical molecular weight of less than 15,000, and being compatible with said base polymer; -
[oligo] is a first oligomeric segment;
[link A] is a second coupling segment linking one [oligo] to another [oligo] within said central portion;
n is 0 to 20;
[fluoro] is a polyfluoro oligomeric group; and
[link B] is a first coupling segment linking said central portion to said [fluoro] through said first coupling segment; and
coupled to a bioactive moiety [Bio] or precursor thereof; and
m is 1 to 20.
-
Specification